Physician profile
Michael H Simons
NPI 1932295029
$1,149.92
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $164 · 2021: $319 · 2022: $48.60 · 2023: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $317.54 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $240.58 | 2021 | |
| Osiris Therapeutics INC. | $167.67 | 2019 | |
| Smith+Nephew, INC. | $123.69 | 2019-2021 | |
| Aroa Biosurgery Incorporated | $57.95 | 2020 | |
| Tactile Systems Technology INC | $57.17 | 2019-2022 | |
| Zyla Life Sciences, INC. | $54.63 | 2019-2020 | |
| Sandoz INC. | $42.52 | 2019-2020 | |
| Depuy Synthes Sales INC. | $34.36 | 2019 | |
| Abbott Laboratories | $19.64 | 2023 | Proclaim |
| Wright Medical Technology, INC. | $18.42 | 2020 | |
| Acell, INC. | $15.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.